Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Credit agrmnt [a]
|
|
Ortho Clinical Diagnostics Holdings plc
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/06/2022 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 05/27/2022 |
8-K
| Quarterly results |
| 05/27/2022 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 05/26/2022 |
8-K
| Quarterly results |
| 05/20/2022 |
8-K
| Quarterly results |
| 05/20/2022 |
8-K/A
| Quarterly results |
| 05/19/2022 |
8-K/A
| Quarterly results |
| 05/18/2022 |
8-K
| Quarterly results |
| 05/16/2022 |
8-K
| Quarterly results |
| 05/09/2022 |
10-Q
| Quarterly Report for the period ended April 3, 2022 |
| 05/06/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 05/06/2022 |
8-K
| Quarterly results |
| 05/04/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 05/04/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 05/04/2022 |
8-K
| Quarterly results |
| 05/02/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 05/02/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/11/2022 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 04/07/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"ORTHO-CLINICAL DIAGNOSTICS HOLDINGS PLC 2021 EQUITY INCENTIVE PLAN 2014 Equity Incentive Plan OMNIBUS AMENDMENT TO AWARD AGREEMENTS This Omnibus Amendment to Award Agreements amends those outstanding award agreements described below relating to share option awards, restricted share units and restricted shares granted by Ortho Clinical Diagnostics Holdings plc or its predecessors under the Company’s 2014 Equity Incentive Plan or the Company’s 2021 Equity Incentive Plan . Capitalized terms not defined herein shall have the meanings set forth in the respective Plan. This Amendment does not, however, amend the terms of, and does not apply to, any Award that is covered by an individual amendment or similar agreement addressing the impact of the Combinations thereon. WHEREAS, the Company has ent...",
"ORTHO CLINICAL DIAGNOSTICS HOLDINGS PLC",
"Restricted Stock Agreement Amendment",
"AMENDED AND RESTATED SPECIAL ADVISOR AGREEMENT THIS AMENDED AND RESTATED SPECIAL ADVISOR AGREEMENT is made and entered as of April 3, 2022 , by and between Coronado Topco, Inc., a Delaware corporation , and Christopher Smith, an individual . BACKGROUND A. On December 22, 2021, the Company entered into a Business Combination Agreement by and among the Company, Ortho Clinical Diagnostics Holdings plc , Quidel Corporation and certain other parties, which provides for the acquisition of Quidel and Ortho by the Company . B. Smith currently serves as the Chairman and Chief Executive Officer of Ortho. C. The Company desires that Smith cease to serve as Chief Executive Officer and commence service as Special Advisor effective upon the consummation of the transactions contemplated by the BCA . D. S..." |
|
| 03/07/2022 |
10-K
| Annual Report for the period ended January 2, 2022 |
| 02/17/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 02/17/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 02/16/2022 |
8-K
| Quarterly results |
| 02/16/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"SPECIAL ADVISOR AGREEMENT THIS SPECIAL ADVISOR AGREEMENT is made and entered as of February 15, 2022, by and between Coronado Topco, Inc., a Delaware corporation , and Christopher Smith, an individual . BACKGROUND 1. On December 22, 2021, the Company entered into a Business Combination Agreement by and among the Company, Ortho Clinical Diagnostics Holdings plc , Quidel Corporation and certain other parties, which provides for the acquisition of Quidel and Ortho by the Company . 2. Smith currently serves as the Chairman and Chief Executive Officer of Ortho. 3. The Company desires that Smith cease to serve as Chief Executive Officer and commence service as Special Advisor effective upon the consummation of the transactions contemplated by the BCA . 4. Smith has previously entered into an Ame..." |
|
| 02/14/2022 |
SC 13G
| PRICE T ROWE ASSOCIATES INC reports a 8.4% stake in Ortho Clinical Diagnostics Holdings plc |
| 02/14/2022 |
8-K
| Other Events Interactive Data |
| 02/14/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 02/11/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/04/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 01/24/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 01/18/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 01/18/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/12/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 01/12/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
|
|
|